Brandywine Global Investment Management LLC Takes Position in Embecta Corp. (NASDAQ:EMBC)

Brandywine Global Investment Management LLC purchased a new position in shares of Embecta Corp. (NASDAQ:EMBC) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 195,768 shares of the company’s stock, valued at approximately $4,043,000. Brandywine Global Investment Management LLC owned 0.34% of Embecta at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Garden State Investment Advisory Services LLC purchased a new stake in shares of Embecta in the third quarter worth about $438,000. Barclays PLC lifted its position in Embecta by 41.1% during the 3rd quarter. Barclays PLC now owns 97,930 shares of the company’s stock worth $1,381,000 after acquiring an additional 28,523 shares in the last quarter. Jane Street Group LLC boosted its holdings in Embecta by 156.1% in the 3rd quarter. Jane Street Group LLC now owns 176,487 shares of the company’s stock worth $2,488,000 after acquiring an additional 107,567 shares during the period. Geode Capital Management LLC grew its position in Embecta by 3.4% in the third quarter. Geode Capital Management LLC now owns 1,387,273 shares of the company’s stock valued at $19,564,000 after acquiring an additional 45,228 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. purchased a new stake in shares of Embecta during the fourth quarter valued at approximately $209,000. 93.83% of the stock is currently owned by institutional investors and hedge funds.

Embecta Trading Down 0.9 %

Shares of EMBC stock opened at $12.63 on Wednesday. The firm has a fifty day simple moving average of $15.02 and a 200-day simple moving average of $16.23. The company has a market capitalization of $734.23 million, a PE ratio of 12.63, a price-to-earnings-growth ratio of 0.78 and a beta of 1.27. Embecta Corp. has a twelve month low of $9.93 and a twelve month high of $21.48.

Embecta (NASDAQ:EMBC) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.65 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.20. Embecta had a net margin of 5.25% and a negative return on equity of 19.22%. Equities research analysts predict that Embecta Corp. will post 2.85 EPS for the current year.

Embecta Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were issued a dividend of $0.15 per share. The ex-dividend date was Friday, February 28th. This represents a $0.60 annualized dividend and a yield of 4.75%. Embecta’s dividend payout ratio is presently 60.00%.

Insider Buying and Selling at Embecta

In related news, Director Milton Mayo Morris sold 3,100 shares of Embecta stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $16.38, for a total value of $50,778.00. Following the completion of the sale, the director now owns 36,133 shares in the company, valued at approximately $591,858.54. The trade was a 7.90 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.42% of the stock is currently owned by corporate insiders.

Embecta Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.